Calcium blocking agents. New directions in the treatment of angina pectoris.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy* / Q000378:metabolism; D002118:Calcium / Q000037:antagonists & inhibitors* / Q000378:metabolism / Q000494:pharmacology; D004110:Diltiazem / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007473:Ion Channels / Q000187:drug effects*; D009200:Myocardial Contraction / Q000187:drug effects; D009543:Nifedipine / Q000494:pharmacology / Q000627:therapeutic use*; D010101:Oxygen Consumption; D011725:Pyridines / Q000627:therapeutic use*; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D007473:Ion Channels; D011725:Pyridines; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine; D002118:Calcium